Global Acid Suppressant Market Size, Share and Trends Analysis Report, By Type (Histamine-2 Blockers, Proton Pump Inhibitors, and Promotility Agent), By Distribution Channel (Hospitals, Drug Retail), Forecast Period (2022-2028)

The global acid suppressant market is anticipated to grow at a CAGR of 4.2% during the forecast period (2022-2028). People aged 70 or older are more prone to peptic ulcers. The growth of the geriatric population across the globe is increasing, so does the customer base for the acid suppressant market. According to the National Institute of Diabetes and Digestive and Kidney Diseases, H. pylori infections affect 30 to 40% of persons in the US. In most cases, the illness goes unnoticed for years, with no signs or symptoms. The majority of people contract H. pylori as children. With such a large market size and a growing patient population around the globe, the acid suppressant industry is expected to develop in the coming years.

Proton-pump inhibitors (PPIs) have now surpassed H2 blockers as the most often prescribed stomach acid-reduction medicines. Lansoprazole (Prevacid), omeprazole (Prilosec), pantoprazole (Protonix), rabeprazole (AcipHex), and esomeprazole are examples of proton pump inhibitors (Nexium). For instance, Cipla Ltd offers Lomac 20mg Capsule, It’s a drug that lowers the quantity of acid produced by the stomach. It aids in the treatment of acid-related stomach and intestinal illnesses such as heartburn, acid reflux, and peptic ulcer disease. 20mg Lomac Capsules are also used to prevent stomach ulcers and acidity, which can occur as a result of long-term painkiller use. It’s a proton pump inhibitor, which is a type of medication.

Infection with the bacteria Helicobacter pylori, or H. pylori, is the principal cause of severe damage. The bacteria can inflame the lining of your duodenum, causing an ulcer to form. Some medications, notably anti-inflammatory drugs like ibuprofen and aspirin, might cause a duodenal ulcer. A history of recurrent or heavy NSAID usage, as well as a diagnosis of H. pylori, are the two main causes of duodenal ulcers. The majority of patients have H. pylori as a secondary diagnosis; nevertheless, as infection rates have decreased, previously unusual etiologies are becoming more common.

Some major players in the market include Eisai Co., Ltd., GlaxoSmithKline plc., Johnson and Johnson Pvt. Ltd., Pfizer Inc., Takeda Pharmaceuticals Company Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, GlaxoSmithKline plc. offers Zinetac 150mg Tablet, It’s a medication that lowers the quantity of acid produced by the stomach. It’s used to treat and prevent heartburn, indigestion, and other symptoms brought on by too much stomach acid. It’s also used to treat and prevent stomach ulcers, reflux illness, and a few other conditions that aren’t as common.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape– Eisai Co., Ltd., GlaxoSmithKline plc., Johnson and Johnson Pvt. Ltd., Pfizer Inc., Takeda Pharmaceuticals Company Ltd. among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Acid Suppressant Market Report by Segment

By Type

• Histamine-2 Blockers
• Proton Pump Inhibitors
• Promotility Agents

By Distribution Channels

• Hospitals
• Drug Retail

Global Acid Suppressant Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa